The Priority Review

Clinical trials Brief

Novo Nordisk posts results of Phase 3 dasiglucagon vs glucagon study in Asian adults with T1D

The study, completed with 38 participants, compared dasiglucagon and glucagon for treating severe hypoglycaemia in Asian adults with type 1 diabetes. Results were first posted on ClinicalTrials.gov on November 16, 2026.

Primary source

ClinicalTrials.gov results record, November 16, 2026

Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents

Read the source: Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation